Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study

Condition:   Asthma
Interventions:   Drug: Fluticasone Furoate/GW642444;   Drug: Fluticasone propionate
Sponsor:   GlaxoSmithKline
Active, not recruiting – verified September 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.